Pharmacologic effects of nicotinic acid on human purine metabolism.
D000328:Adult; D001241:Aspirin / Q000494:pharmacology; D003404:Creatinine / Q000097:blood; D004912:Erythrocytes / Q000032:analysis / Q000201:enzymology; D005260:Female; D006073:Gout / Q000188:drug therapy; D006801:Humans; D007480:Iopanoic Acid / Q000494:pharmacology; D007684:Kidney Tubules / Q000187:drug effects / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009536:Niacinamide / Q000494:pharmacology; D009539:Nicotinic Acids / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D009943:Organophosphorus Compounds / Q000097:blood; D010428:Pentosephosphates / Q000097:blood; D010430:Pentosyltransferases / Q000097:blood; D010756:Phosphoric Acids / Q000097:blood; D011687:Purines / Q000096:biosynthesis / Q000378:metabolism*; D011718:Pyrazinamide / Q000494:pharmacology; D011725:Pyridines / Q000378:metabolism; D013442:Sulfinpyrazone / Q000494:pharmacology; D014527:Uric Acid / Q000097:blood* / Q000378:metabolism / Q000652:urine
D009539:Nicotinic Acids; D009943:Organophosphorus Compounds; D010428:Pentosephosphates; D010756:Phosphoric Acids; D011687:Purines; D011725:Pyridines; D009536:Niacinamide; D014527:Uric Acid; D011718:Pyrazinamide; D003404:Creatinine; D010430:Pentosyltransferases; D007480:Iopanoic Acid; D001241:Aspirin; D013442:Sulfinpyrazone